February 6, 2017 8:30 - 16:30 Hrs
BioPark Visit
18:00 - 19:30 Hrs
Inauguration of the 14th BioAsia Convention (Presentation of Genome Valley Excellence Award)
19:30 - 20:00 Hrs
Visit to the exhibition
20:00 Hrs
Welcome Reception (only for invitees) February 7, 2017
8:30 – 9:20 Hrs
India-Illinois Power Breakfast Meeting (Only for Invitees)
9:30 - 10: 00 Hrs
Keynote Addresses: Nobel Laureate Prof. Kurt Wuthrich, Scripps Research Institute, USA
10:00 - 10: 30 Hrs
Keynote Address: Dr. Paul Stoffels, Worldwide Chairman of Pharma, Chief Scientific Officer, Johnson & Johnson, USA
10:30 - 11: 00 Hrs
Keynote Address: Dr. Vasant Narasimhan, Global Head of Drug Development & CMO, Novartis, Switzerland
11:00 - 11:30 Hrs
Networking Break & Visit to the Exhibition Innovation Conference Plenary Address on Disruptive Innovation Emerging technologies - nanobots, combination devices, 3D printing Traditional vs innovation approach to clinical research/biotech-pharma research Companies leading the way (Google) &Industry trends
11:30 – 12:15 Hrs 12:15 – 13:30 Hrs
Speakers: Enabling Open Innovation (Panel Discussion) Introduction to open innovation Solving complex problems with open innovation model Executing an open innovation model Pitfalls to avoid Opening Remarks: Dr. Renu Swarup, MD, BIRAC, Dept. of Biotechnology, Govt. of India Chairman: Mr. BVR Mohan Reddy, Founder & Chairman, Cyient, India Panelists: Padma Vibhushan Dr. R A Mashelkar, National Research Professor & President, Global ResearchAlliance& Former DG, CSIR Dr. Murtaza Khorakiwala, Managing Director, Wockhardt, India Mr. Ranjit Shahani, Chairman &MD, Novartis, India* Mr. Manni Kantipudi, CEO, GVK Biosciences, India* Mr. Edgard Olaizola,Managing Director, Eli Lilly India* Mr. Brian Toohley, SVP International, Pharmaceutical Research & Manufacturers of America (PhRMA), USA
Automation in Diagnostics Conference Under Chairmanship of Dr. Shanthi Naidu
TB Conference TBD
Mr.
Moderator:Pad Distinguished Scientist Eye Institute 13:30 – 14:30 Hrs
Mohan Pandey, &Head of BBRC Center), Bristol-Myers
Executive Director (Biocon BMS R&D Squibb
ma Shri Dr. D & Director Emeritus -
Balasubramanian, Research, LV Prasad
Networking Lunch& Visit to the Exhibition Patent protection and value of Innovation and R&D Ways for pharma companies to continue to innovate in this new world and come up with drugs of the future Patent protection to help fuel that growth of innovation (by providing protection from infringement, continuing to provide sufficient time to help invest in innovation) Pharma companies taking additional investments to ensure compliance with regulations and meet the larger goal of improving health outcomes.
14:30 – 15:45 Hrs
15:45 – 16:15 Hrs
16:15 – 17:30 Hrs
Panelists: Mr. Rajiv Aggarwal, Joint Secretary, DIPP, Govt. of India &Convenor of the Innovation Task Force, Cell for IPR Promotion and Management (CIPAM), DIPP* Dr. Anil Koul, Director, CSIR-Institute of Microbial Technology, India Dr. S. Chandrasekhar, Director, CSIR-Indian Institute of Chemical Technology Mr. K G Ananthakrishnan, Managing Director, MSD India Dr. Krishna Ella, Chairman & Managing Director, Bharat Biotech International Ltd., India* Ms. Amiee Aloi Associate Vice President, International Advocacy, PhRMA, USA Prof. Prabhudha Ganguli, Advisor, VISION-IPR, India* Networking Lunch& Visit to the Exhibition Design Led Thinking Finding the right problem Essential principles and frameworks How biotech/pharma embraces the principles of design led thinking Chairman: Padma Shri Dr. D Balasubramanian, Distinguished Scientist & Director Emeritus Research, LV Prasad Eye Institute Panelists: Mr. Parameswaran Venkataraman,VP & Studio 5B Lead,Innovation and Design Centre, Dr. Reddy's Laboratories Mr. Yashdeep Kumar, Vice President, Global Innovation Programs, Stryker Corporation, USA Mr. Manoj Kothari, Managing Director- Turian Labs, Co-founder- Onio Design Pvt. Ltd Dr. Arun Mazumdar, Stanford University, USA* Moderator: Mr. Sudeep Krishna, Senior Director and Head Lifesciences, Monitor Deloitte - Deloitte Consulting
17:30 – 18:30 Hrs
Networking Break& Visit to the Exhibition
18:30 - 20:00 Hrs
CEO CONCLAVE SERVING A BILLION NEW PATIENTS - Role that Indian Life Sciences Industry can play Panelists:
Shri.
KT Rama Rao, Hon’ble Communication, Development and NRI Amitabh Kant, CEO, Vas Narasimhan,
Mr. Mr. (worldwide) for Novartis Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories Mr. Nilesh Gupta, Managing Director, Lupin* Mr. Glenn Saldhana, Chairman and Managing Director, Glenmark Pharmaceuticals Mr. Bhaskar Iyer, Vice President, Established Pharmaceuticals, Abbott, India
Minister for Industries, IT, Electronics, Municipal Administration, Urban Affairs, Government of Telangana NITI Aayog, Government of India* Global Head of Drug Development and Chief Medical Officer
February 8, 2017 8:30 – 9:20 Hrs
BioAsia OPPI Women in Pharma Breakfast Session (Only for Invitees)
9:30 - 10: 00 Hrs
Keynote Addresses: Mr. Narayana Murthy, Founder, Infosys
10:00 - 10: 30 Hrs
Keynote Addresses: Dr. Patrick Vallance, President R&D, GSK, UK Manufacturing Conference
10:30 – 11:45 Hrs
11:45 – 12:15 Hrs
Digital Health and Healthcare IT Conference
The Power of Manufacturing Clusters – Make in India (Panel Discussion) Govt. initiatives to promote pharmaceutical manufacturing Infrastructure, incentives, and advantage offered by manufacturing clusters Investment opportunities Are we on the right track?
Health IT - Adoption in India (Panel Discussion) IT penetration in Indian healthcare landscape Lessons from other markets Innovations, Current and emerging technologies Challenges to adoption How technology enabled care can transform healthcare Telemedicines
Panelists: Mr. Sudhansh Pant, Joint Secretary, Department of Pharmaceuticals, Government of India* Mr. Sudhanshu Pandey, Joint Secretary, Department of Commerce, Government of India* Dr. VM Katoch, Former Secretary, Health Research & Former DG, ICMR Mr. R Ananthanarayanan, President & CEO, Teva Pharmaceutical Industries Ltd.* Mr. Srini Srinivasan, MD, Hospira Mr. Mathew Szuhaj, Managing Director, Deloitte Mr. Milan Rao, President & CEO, GE Healthcare - India & South Asia, GE Healthcare* Mr. Kal Sundaram, India CEO, Sun Pharma* Dr. Sharvil P. Patel, Deputy Managing Director, Zydus Cadila*
Chairman: Ms. Sangita Reddy, Joint Chairman, Apollo Hospitals* Speakers: Mr. Anil Bhansali, MD, Microsoft India (R&D) Pvt. Ltd.* Mr. N. Chandrasekaran, CEO & Managing Director, TCS India* Ms. Vanitha Narayanan, Managing Director, IBM India Private Limited * Mr. Dinesh Malkani, President, Cisco India* Mr. Srinivas Prasad, CEO, Philips Innovation Campus* Dr. Harish Iyer, Advisor, Bill & Melinda Gates Foundation Mr. Mukesh Rathi,VP & CIO, Dr. Reddy's Laboratories* Ms. Swati Subodh, Cofounder & Director, Healthcare Innovations Mr. Jeyaseelan Jeyaraj, Director Oracle Health Sciences, Asia Pacific Oracle Corporation* Mr. Joe Kvedar, Vice President of Connected Health, Partners HealthCare*
Networking Break& Visit to the Exhibition
Moderator:Dr. Anthony Vipin Das, LV Prasad Eye Institute
Health & Access Conference
In partnership with IFCAI
Manufacturing (Q&A Session) 12:15 – 13:30 Hrs
- Impact of regulators
Digital Health: Will startups drive the growth? (Panel Discussion) India's healthcare startup story Government initiatives supporting
Quality and regulatory concerns Limitations of current
regulatory regime Industry response to the increased regulatory scrutiny
Panelists: Dr. Mathew T. Thomas, Director India, USFDA* Mr. Rajeev Nannapaneni, VC & CEO, Natco Pharma* Dr. GN Singh, DCGI, Chairman, CDCSO India* Mr.N Govindarajan, Managing Director, Aurobindo Pharma* Dr. Mahesh Bhalgat, ED & COO, Shantha Biotechnics Mr. R.C. Juneja, CEO & Chairman, Mankind Pharma Ltd.* Dr. Satyanarayana Chava, CEO, Laurus Labs* Ms. Mahima Datla, Sr. Vice President, Biological E. Ltd.*
entrepreneurs Chair: Mr. Rajan Anandan , Vice President, South East Asia and India, Google* Speakers: Mr. CP Gurnani, CEO and Managing Director, Tech Mahindra Mr. Shashank ND, Founder & CEO, Practo Mr. Prashant Tandon, Co-founder, 1 Mg Mr. Bobba Venkatadri, General Partner, Ventureast Mr. Apoorva Patni, Director, Currae Healthcare - Patni Enterprise Dr. Anand Gnanaraj, Founding Member & CMO, Attune Technologies* Moderator:Mr. Jay Krishnan, CEO, T-hub Hyderabad
13:30 – 14:30 Hrs
14:30 – 15:45 Hrs
15:45 – 16:15 Hrs 16:15 – 17:15 Hrs
Networking Lunch & Visit to the Exhibition GST and its Impact on Supply Chain (Panel Discussion) Impact of GST on business operations Place of Supply provisions impact on procurement & distribution New supply chain models Panelists: Mr. S Sridhar, MD, Pfizer India Mr. A. Vaidheesh, VP, South Asia & MD India, GSK Mr. Anurag Roy,VP & Business Unit Director, DSM Sinochem Pharmaceuticals, India Dr. Rajiv Modi, CMD, Cadila Pharmaceuticals* Mr. Umang Vohra, MD & Global CEO, Cipla* Mr. Varun Khanna, MD, BD India* Dr. Cyrus Karkaria, President Biotechnology, Lupin* Dr. Shravan Subramanyam, Managing Director, Roche Diagnostics India & Neighboring Markets* Networking Break& Visit to the Exhibition
Investments & Funding in Digital Health (Panel Discussion) Current investment focus within healthcare Major drivers for investments Opportunities for emerging players/start-ups Speakers: TBD, Saif Partners* TBD, TPG* Mr. Bobba Venkatadri, General Partner, Ventureast TBD, Nexus*
Start-Up &Healthcare Challenge Session